Skip to main content
. Author manuscript; available in PMC: 2009 Apr 8.
Published in final edited form as: Br J Haematol. 2008 Dec 10;144(4):603–612. doi: 10.1111/j.1365-2141.2008.07509.x

Figure 3.

Figure 3

Multilineage engraftment of hoxb4-expanded human cord blood CD34+ cells. Representative flow cytometry profile of engrafted BM cells in mice received BSA or T-hoxb4-H treated human cord blood CD34+ cells. Human cord blood CD34+ cells were cultured for 4 days with 50nM BSA or T-hoxb4-H. Cells were then collected and injected into sublethally irradiated NOD/SCID mice, with each recipient received cells equivalent to 104 or 5×103 starting CD34+ cells in a SRC assay as detailed in Material and Methods. Recipient BM cells were harvested eight weeks later and stained for human myeloid (CD14/CD15) and lymphoid (CD19) markers.